\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\	multiple\\ scattered\\ and\\ isolated\\ erythematous\\ papules\\,\\ papulovesicles\\,\\ necrotic\\ papules\\ and\\ crusted\\ plaques\\.\\ these\\ numbered\\ between\\ 12\\-15\\ lesions\\ and\\ were\\ distributed\\ on\\ the\\ arms\\,\\ thighs\\,\\ calves\\,\\ and\\ feet\\.\\ \ \(0\)\
\-\ laboratory\\:\\	wbc\\ \\=\\ 8\\.4\\;\\ esr\\ \\=\\ lmm\\;\\ rpr\\ \\=\\ nr\\;\\ chest\\ x\\-ray\\ \\=\\ normal\\ \ \(0\)\
\-\ histopathology\\:\\ band\\-like\\ dermal\\ infiltrate\\ invading\\ the\\ epidermis\\ with\\ epidermal\\ necrosis\\ and\\ vacuolopathy\\.\\ the\\ lymphocytes\\ are\\ atypical\\ with\\ pleomorphism\\ and\\ several\\ with\ \(0\)\
\-\ hyperchromatic\\ cerebriform\\ nuclei\\.\ \(1\)\
\-\ no\\ response\\ to\\ eight\\ weeks\\ of\\ tetracycline\\ and\\ topical\ \(0\)\
\-\ clobetasol\\.\\ intralesional\\ triamcinolone\\ does\\ seem\\ to\ \(0\)\
\-\ halt\\ progression\\ to\\ necrosis\\ and\\ scarring\\.\\ to\\ date\\ no\ \(0\)\
\-\ adenopathy\\ has\\ developed\\ and\\ the\\ patient\\ has\\ a\\ normal\\ chest\\ x\\-ray\\.\ \(0\)\
\-\ lymphomatoid\\ papulosis\\ \\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\#18b\\)\\ submitted\\ by\\:\\ lcdr\\ bradley\\ s\\.\\ graham\\,\\ mc\\,\\ usnr\ \(0\)\
\-\ presented\\ with\\ a\\ 2\\ week\\ history\\ of\\ crops\\ of\\ papules\\,\\ blisters\\,\\ and\\ ulcers\\.\\ starting\\ first\\ on\\ the\\ right\\ arm\\,\\ the\\ lesions\\ subsequently\\ spread\\ to\\ involve\\ his\\ abdomen\\ and\\ lower\\ legs\\.\\ other\\ than\\ pain\\ with\\ ulceration\\,\\ the\\ lesions\\ were\\ asymptomatic\\.\\ no\\ history\\ of\\ weight\\ loss\\,\\ fatigue\\ or\\ fever\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ papules\\:\\ 0\\.2822023970235324\ \(0\)\
\-\ and\\:\\ 0\\.1870737094514639\ \(0\)\
\-\ lesions\\:\\ 0\\.14180091812049267\ \(0\)\
\-\ papulovesicles\\:\\ 0\\.1316188165822385\ \(0\)\
\-\ numbered\\:\\ 0\\.1316188165822385\ \(0\)\
\-\ lmm\\:\\ 0\\.1316188165822385\ \(0\)\
\-\ vacuolopathy\\:\\ 0\\.1316188165822385\ \(0\)\
\-\ cerebriform\\:\\ 0\\.1316188165822385\ \(0\)\
\-\ 18b\\:\\ 0\\.1316188165822385\ \(0\)\
\-\ necrosis\\:\\ 0\\.12582127845318364\ \(0\)\
\-\ papulosis\\:\\ 0\\.12576880586426473\ \(0\)\
\-\ crusted\\:\\ 0\\.1216181572053353\ \(0\)\
\-\ calves\\:\\ 0\\.1216181572053353\ \(0\)\
\-\ hyperchromatic\\:\\ 0\\.1216181572053353\ \(0\)\
\-\ clobetasol\\:\\ 0\\.1216181572053353\ \(0\)\
\-\ triamcinolone\\:\\ 0\\.1216181572053353\ \(0\)\
\-\ blisters\\:\\ 0\\.1216181572053353\ \(0\)\
\-\ pleomorphism\\:\\ 0\\.11839866398451143\ \(0\)\
\-\ tetracycline\\:\\ 0\\.11839866398451143\ \(0\)\
\-\ halt\\:\\ 0\\.11839866398451143\ \(0\)\
\-\ lymphomatoid\\:\\ 0\\.11839866398451143\ \(0\)\
\-\ bradley\\:\\ 0\\.11839866398451143\ \(0\)\
\-\ crops\\:\\ 0\\.11839866398451143\ \(0\)\
\-\ graham\\:\\ 0\\.11576814648736153\ \(0\)\
\-\ the\\:\\ 0\\.11495561950963479\ \(0\)\
\-\ nr\\:\\ 0\\.11354407563357098\ \(0\)\
\-\ lcdr\\:\\ 0\\.11161749782843211\ \(0\)\
\-\ usnr\\:\\ 0\\.11161749782843211\ \(0\)\
\-\ epidermis\\:\\ 0\\.10461263879324896\ \(0\)\
\-\ intralesional\\:\\ 0\\.10461263879324896\ \(0\)\
\-\ thighs\\:\\ 0\\.10354341625666778\ \(0\)\
\-\ to\\:\\ 0\\.10287669275293615\ \(0\)\
\-\ rpr\\:\\ 0\\.10161683845152891\ \(0\)\
\-\ seem\\:\\ 0\\.10161683845152891\ \(0\)\
\-\ distributed\\:\\ 0\\.10074215236804811\ \(0\)\
\-\ epidermal\\:\\ 0\\.097693405538694\ \(0\)\
\-\ topical\\:\\ 0\\.097693405538694\ \(0\)\
\-\ dermal\\:\\ 0\\.09638087366629756\ \(0\)\
\-\ invading\\:\\ 0\\.09576682773355513\ \(0\)\
\-\ lymphocytes\\:\\ 0\\.09254733451273126\ \(0\)\
\-\ starting\\:\\ 0\\.09254733451273126\ \(0\)\
\-\ eight\\:\\ 0\\.09207424617265197\ \(0\)\
\-\ nuclei\\:\\ 0\\.09074149299114491\ \(0\)\
\-\ ulceration\\:\\ 0\\.08991681701558137\ \(0\)\
\-\ infiltrate\\:\\ 0\\.08735325045847084\ \(0\)\
\-\ submitted\\:\\ 0\\.08702155994965481\ \(0\)\
\-\ chest\\:\\ 0\\.08688633326865529\ \(0\)\
\-\ ulcers\\:\\ 0\\.08669732379475747\ \(0\)\
\-\ mc\\:\\ 0\\.08638021428939437\ \(0\)\
\-\ scarring\\:\\ 0\\.08489148227317113\ \(0\)\
\-\ were\\:\\ 0\\.08484860663414223\ \(0\)\
\-\ erythematous\\:\\ 0\\.08354209750286139\ \(0\)\
\-\ plaques\\:\\ 0\\.08303580339049842\ \(0\)\
\-\ arms\\:\\ 0\\.08303580339049842\ \(0\)\
\-\ histopathology\\:\\ 0\\.08303580339049842\ \(0\)\
\-\ seminar\\:\\ 0\\.08278916658656678\ \(0\)\
\-\ uniformed\\:\\ 0\\.08207358679574878\ \(0\)\
\-\ 1997\\:\\ 0\\.08139182681861867\ \(0\)\
\-\ legs\\:\\ 0\\.08095458421545905\ \(0\)\
\-\ services\\:\\ 0\\.08074083361424171\ \(0\)\
\-\ with\\:\\ 0\\.0805788034832066\ \(0\)\
\-\ dermatology\\:\\ 0\\.08053020357142059\ \(0\)\
\-\ no\\:\\ 0\\.08029102256869936\ \(0\)\
\-\ necrotic\\:\\ 0\\.08011794976288378\ \(0\)\
\-\ fatigue\\:\\ 0\\.07971714894299255\ \(0\)\
\-\ isolated\\:\\ 0\\.07821679557963382\ \(0\)\
\-\ feet\\:\\ 0\\.07735259108156764\ \(0\)\
\-\ date\\:\\ 0\\.07606926549786656\ \(0\)\
\-\ response\\:\\ 0\\.07591658786478674\ \(0\)\
\-\ progression\\:\\ 0\\.07546801593109706\ \(0\)\
\-\ esr\\:\\ 0\\.07532153851370725\ \(0\)\
\-\ has\\:\\ 0\\.07518631183270773\ \(0\)\
\-\ spread\\:\\ 0\\.07393316992695209\ \(0\)\
\-\ involve\\:\\ 0\\.07242628144778071\ \(0\)\
\-\ scattered\\:\\ 0\\.07161486032081932\ \(0\)\
\-\ subsequently\\:\\ 0\\.0702192547798928\ \(0\)\
\-\ adenopathy\\:\\ 0\\.06923065572898982\ \(0\)\
\-\ atypical\\:\\ 0\\.06752068101651464\ \(0\)\
\-\ normal\\:\\ 0\\.06720671019202179\ \(0\)\
\-\ arm\\:\\ 0\\.06568989929565199\ \(0\)\
\-\ of\\:\\ 0\\.06442454913380935\ \(0\)\
\-\ history\\:\\ 0\\.0628882577066886\ \(0\)\
\-\ developed\\:\\ 0\\.061061340136943094\ \(0\)\
\-\ laboratory\\:\\ 0\\.059765325612302196\ \(0\)\
\-\ wbc\\:\\ 0\\.0581710148439884\ \(0\)\
\-\ weight\\:\\ 0\\.05739327498242953\ \(0\)\
\-\ does\\:\\ 0\\.0568971377882535\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.056029625601508884\ \(0\)\
\-\ fever\\:\\ 0\\.055801811894426706\ \(0\)\
\-\ first\\:\\ 0\\.05554049734683852\ \(0\)\
\-\ week\\:\\ 0\\.055356699935312226\ \(0\)\
\-\ several\\:\\ 0\\.05399818647017805\ \(0\)\
\-\ between\\:\\ 0\\.053475852443223997\ \(0\)\
\-\ abdomen\\:\\ 0\\.0502179360260864\ \(0\)\
\-\ loss\\:\\ 0\\.05014139525406309\ \(0\)\
\-\ his\\:\\ 0\\.04991417950796857\ \(0\)\
\-\ on\\:\\ 0\\.04971323390540307\ \(0\)\
\-\ weeks\\:\\ 0\\.04932520378429458\ \(0\)\
\-\ presented\\:\\ 0\\.04799386517229585\ \(0\)\
\-\ than\\:\\ 0\\.04665466434278915\ \(0\)\
\-\ these\\:\\ 0\\.04647592686737724\ \(0\)\
\-\ physical\\:\\ 0\\.04462603418959005\ \(0\)\
\-\ other\\:\\ 0\\.042740750399547195\ \(0\)\
\-\ lower\\:\\ 0\\.042056412358252616\ \(0\)\
\-\ exam\\:\\ 0\\.04143086840119992\ \(0\)\
\-\ case\\:\\ 0\\.041347630275966676\ \(0\)\
\-\ multiple\\:\\ 0\\.04025569984549692\ \(0\)\
\-\ by\\:\\ 0\\.03495020286935813\ \(0\)\
\-\ are\\:\\ 0\\.03122986625584275\ \(0\)\
\-\ pain\\:\\ 0\\.0294506847315238\ \(0\)\
\-\ or\\:\\ 0\\.028631400600443495\ \(0\)\
\-\ right\\:\\ 0\\.027286518601185153\ \(0\)\
\-\ patient\\:\\ 0\\.026768709227722128\ \(0\)\
